Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 122 | 129 | +7 |
| Shares | 69.8M | 75.8M | +5.97M (+8.6%) |
| Value | $715.1M | $611.7M | −$103.4M (−14.5%) |
New holders (27)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (20)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 1,732,571 | $17.8M |
| Driehaus Capital Management LLC | 119,083 | $1.22M |
| Deerfield Management Company, L.P. (Series C) | 78,435 | $804.0K |
| Jane Street Group, LLC | 47,849 | $490.5K |
| EntryPoint Capital, LLC | 28,580 | $292.9K |
| Campbell & CO Investment Adviser LLC | 27,241 | $279.2K |
| Trexquant Investment LP | 25,220 | $258.5K |
| Corton Capital Inc. | 17,440 | $178.8K |
| Squarepoint Ops LLC | 16,666 | $170.8K |
| Renaissance Technologies LLC | 13,700 | $140.4K |
| Connor, Clark & Lunn Investment Management Ltd. | 12,832 | $131.5K |
| Creative Planning | 11,272 | $115.5K |
| Ameriprise Financial Inc | 11,109 | $113.9K |
| LPL Financial LLC | 10,731 | $110.0K |
| Cornercap Investment Counsel Inc | 10,063 | $103.1K |
| Acadian Asset Management LLC | 2,309 | $23.0K |
| Smartleaf Asset Management LLC | 870 | $9.27K |
| NBC Securities, Inc. | 118 | $1.00K |
| Bessemer Group Inc | 120 | $1.00K |
| Capital Performance Advisors LLP | 1 | $10 |